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Phloretin (PT), isolated from the apple tree, was previously demonstrated to have 
antioxidative and anti-inflammatory effects in macrophages and anti-adiposity effects in 
adipocytes. Inflammatory immune cells generate high levels of reactive oxygen species 
(ROS) for stimulated severe airway hyperresponsiveness (AHR) and airway inflamma-
tion. In this study, we investigated whether PT could reduce oxidative stress, airway 
inflammation, and eosinophil infiltration in asthmatic mice, and ameliorate oxidative and 
inflammatory responses in tracheal epithelial cells. BALB/c mice were sensitized with 
ovalbumin (OVA) to induce asthma symptoms. Mice were randomly assigned to the five 
experimental groups: normal controls; OVA-induced asthmatic mice; and OVA-induced 
mice injected intraperitoneally with one of the three PT doses (5, 10, or 20  mg/kg). 
In addition, we treated inflammatory human tracheal epithelial cells (BEAS-2B cells) 
with PT to assess oxidative responses and the levels of proinflammatory cytokines 
and chemokines. We found that PT significantly reduced goblet cell hyperplasia and 
eosinophil infiltration, which decreased AHR, inflammation, and oxidative responses in 
the lungs of OVA-sensitized mice. PT also decreased malondialdehyde levels in the lung 
and reduced Th2 cytokine production in bronchoalveolar lavage fluids. Furthermore, PT 
reduced ROS, proinflammatory cytokines, and eotaxin production in BEAS-2B cells. 
PT also suppressed monocyte cell adherence to inflammatory BEAS-2B cells. These 
findings suggested that PT alleviated pathological changes, inflammation, and oxidative 
stress by inhibiting Th2 cytokine production in asthmatic mice. PT showed therapeutic 
potential for ameliorating asthma symptoms in the future.
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inTrODUcTiOn
Allergic asthma is a complex, chronic inflammatory airway disease. Patients with sudden, acute 
asthma attacks exhibit shortness of breath, dry coughing, chest tightness, paroxysmal wheezing due 
to airway obstruction, troubled breathing, and even death (1). In recent years, public health surveys 
found that the mortality due to acute asthma was increasing in developing countries (2). Asthma 
progression involves pathology in the respiratory system, characterized by airway smooth muscle 
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proliferation, the airway narrowing, and goblet cell hyperplasia, 
accompanied by mucus hypersecretion, pulmonary eosinophilia, 
and airway hyperresponsiveness (AHR) (3, 4).
Recent studies have shown that the bronchial asthma is an 
inappropriate anaphylactic immune response to chronic lung 
inflammatory disease. Several immune cells, including Th2 
cells, mast cells, eosinophils, and airway epithelial cells, secrete 
cytokines, chemokines, and inflammatory mediators that damage 
lung tissue and lead to the restricted breathing (4). Importantly, 
activated Th2 cells release additional cytokines, including IL-4, 
IL-5, and IL-13, to stimulate IgE production, which then causes 
mast cell activation, goblet cell hyperplasia, with excessive mucus 
secretion, eosinophil infiltration, and AHR (5). Furthermore, 
inflammatory immune cells, including eosinophils, neutrophils, 
monocytes, and epithelial cells, generate high levels of reactive 
oxygen species (ROS) to damage lung tissue (6, 7). Hence, asthma 
progression may be ameliorated by regulating the activity of Th2 
cells and reducing the infiltration of inflammatory immune cells.
Phloretin (PT), a flavonoid of the chalcone class, is found in 
the fruit, leaves, and bark of apple trees (8). PT has many bio-
logical functions; it was shown to regulate glucose transporters, 
promote apoptosis in tumor cells, and enhance lipid metabolism 
to defend against obesity (9, 10). PT was also found to have anti-
oxidase activity, which reduced oxidative damage in a rat model 
of cerebral ischemia (11).
Our earlier studies demonstrated that PT reduced the inflam-
matory and oxidative stress in LPS-induced acute lung injury 
mice (12). PT also suppressed inflammatory mediator expression 
in IL-1β-stimulated lung epithelial cells (10). Therefore, we rea-
soned that PT might improve asthma by blocking inflammatory 
responses and oxidative stress. In the current study, we treated 
asthmatic mice with intraperitoneal injections of PT to investi-
gate whether PT could ameliorate the pathogenesis of asthma. We 
evaluated inflammation, oxidative stress, and immune function 
in asthmatic mice.
aniMals anD MeThODs
animals
Female BALB/c mice (6–8  weeks old) were obtained from the 
National Laboratory Animal Center in Taiwan. All mice were 
housed in air-conventional animal housing with food and water 
ad  libitum. Animal care and experimental procedures were 
performed in accordance with the guidelines of the Laboratory 
Animal Care Committee of Chang Gung University of Science 
and Technology (IACUC approval number: 2014-023).
sensitization, airway challenge, and Drug 
Treatment
Phloretin (extracted from apple wood; ≥99% purity by HPLC; 
purchased from Sigma-Aldrich, St. Louis, MO, USA) was dis-
solved in DMSO. Mice were sensitized with intraperitoneal 
injections (200 µl) that contained 50 µg ovalbumin (OVA; Sigma, 
St. Louis, MO, USA) mixed with 2  mg aluminum hydroxide 
(Thermo, Rockford, IL, USA) in normal saline. Injections were 
performed on days 1–3 and 14, as described previously (13). On 
days 14, 17, 20, 23, and 27, mice were challenged with inhalations 
of 2% OVA for 30  min, delivered with an ultrasonic nebulizer 
(DeVilbiss Pulmo-Aide 5650D, USA). One hour before the OVA 
inhalation challenge, mice were treated with or without intraperi-
toneal injections of PT. Then, the OVA challenge was followed 
by an AHR assay. Mice were randomly divided into five groups 
(12 mice each), as follows: healthy mice sensitized with normal 
saline and were given equal volume of DMSO by intraperitoneal 
injection (N group) (2); mice sensitized with OVA and were 
given equal volume of DMSO by intraperitoneal injection (OVA 
group); OVA-sensitized mice treated with 5, 10, or 20 mg/kg PT 
(PT5, PT10, and PT20 groups, respectively).
Measurement of ahr
Airway hyperresponsiveness was measured to assess airway 
function after inhaling aerosolized methacholine, as described 
previously (14). All mice inhaled 0–40 mg/ml methacholine for 
3 min; then, mice were placed in a single-chamber, whole-body 
plethysmograph (Buxco Electronics, Troy, NY, USA) to record 
the enhanced pause (Penh), a variable for estimating the AHR.
splenocyte cultures and serum collection
Splenocytes (5  ×  106  cells/ml) were isolated and cultured in 
RPMI 1640 medium containing 10% FBS (Biological Industries, 
Haemek, Israel), 100  U/ml penicillin and streptomycin, and 
100 µg/ml OVA for five continuous days. The supernatants were 
collected, and cytokine concentrations were measured, as previ-
ously described (13).
Blood collected from the orbital vascular plexus and centri-
fuged at 6,000  rpm for 5  min. The serum collected and stored 
at −80°C as previously described. Serum was measure OVA-
specific antibodies with an enzyme-linked immunosorbent assay 
(ELISA).
histological analysis of lung Tissue
Lung tissues were fixed in 10% formalin, embedded in paraffin, 
and cut into sections 6  μm thick. Sections were stained with 
hematoxylin and eosin (HE), to examine eosinophil infiltration 
Inflammatory index calculated and evaluated score using five-
point scoring system as described previously (15). The score were 
considered by the inflammatory cell infiltration on perivascular 
regions and peribronchial of lungs. Furthermore, tracheal sec-
tions were stained with the periodic acid-Schiff (PAS) staining 
system (Sigma), to measure goblet cell hyperplasia, as described 
previously (14).
Malondialdehyde (MDa) activity
We measured MDA activity in lung tissues with the lipid per-
oxidation assay kit, according to the manufacturer’s instructions 
(Sigma). MDA activity was measured as nanomolars of MDA in 
milligram weight of wet tissue with a Multi-Mode Microplate 
Reader (BioTek SynergyHT, Bedfordshire, UK).
glutathione (gsh) assay
To detect glutathione levels in lung tissues, we employed a glu-
tathione assay kit, according to the manufacturer’s instructions 
TaBle 1 | Primers used in real-time Pcr analyses of cytokine and chemokine mrna expression levels.
gene Primer forward Primer reverse
CCL11 GGCTTCATGTAGTTCCAGAT CCATTGTGTTCCTCAATAATCC
CCL24 AGGCAGTGAGAACCAAGT GCGTCAATACCTATGTCCAA
COX-2 ACCAGCAGTTCCAGTATCAGA CAGGAGGATGGAGTTGTTGTAG
Gob5 AATGGATGAATGGCTCAGTGAT TATTGTAGGAGGATGCGTTGTC
Intercellular adhesion molecule 1 AACAGAATGGTAGACAGCAT TCCACCGAGTCCTCTTAG
IFN-γ CAGCAACAACATAAGCGTCATT ACCTCAAACTTGGCAATACTCA
IL-4 TCCGTGCTTGAAGAAGAACTC GTGATGTGGACTTGGACTCATT
IL-5 ATCCTCCTGCCTCCTCTTCC GGTTCCATCTCCAGCACTTCA
IL-13 GCTCCAGCATTGAAGCAGTG CGTGGCAGACAGGAGTGTT
iNOS TTCCACAACCACCTCAAGCA TTAAGGCATCACAGTCCGAGTC
MUC5AC AATGCTGGTGCCTGTGTCT CCTCCTATGCCATCTGTTGTG
β-Actin AAGACCTCTATGCCAACACAGT AGCCAGAGCAGTAATCTCCTTC
3
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(Sigma). The kit measured total glutathione, glutathione disulfide, 
and reduced glutathione. The glutathione reaction was measured 
spectrophotometrically at 412  nm with a microplate reader 
(Multiskan FC, Thermo, Waltham, MA, USA). Glutathione 
expressed as nanomolars of MDA in milligram weight of wet 
tissue.
Bronchoalveolar lavage Fluid (BalF) and 
cell counting
Mice were anesthetized and sacrificed to collect BALF, as 
described previously (16). Mouse tracheas were intubated with 
an indwelling needle to wash the lungs with normal saline. The 
supernatants would assay cytokine and chemokine levels. We 
used Liu stain solution (Polysciences, Inc., Taipei, Taiwan) to 
differentiate cell morphology and determine cells counts.
enzyme-linked immunosorbent assay
Serum OVA-specific antibodies, including IgE and IgG1, were 
measured with a specific ELISA kit (BD Biosciences). Serum 
of OVA-sensitized mice makes OVA-IgG1 standard curves for 
determining the concentrations of IgG1. Serum was diluted 
fivefold to detect the absorbance of OVA-IgE at an optical den-
sity of 450  nm, as previously described (14). Furthermore, the 
cell culture supernatants and BALF were used to measure with 
specific ELISA kits to detect the concentrations of CCL5, CCL11, 
CCL24, CCL26, intercellular adhesion molecule 1 (ICAM-1), 
IL-4, IL-5, IL-6, IL-8, IL-13, MCP-1, and tumor necrosis factor-α 
(TNF-α), according to the manufacturer’s instructions (R&D 
Systems, Minneapolis, MN, USA), as previously described (16).
rna isolation and real-time Pcr
Lung tissues were homogenized, and RNA was extracted with 
TRIzol reagent (Life Technologies, Carlsbad, CA, USA); comple-
mentary DNA (cDNA) was generated from 1 µg total RNA using 
cDNA synthesis kit (Life Technologies). cDNA gene expression 
assayed by real-time PCR performed with the SYBR Green system 
(Fermentas, Thermo, Waltham, MA, USA) and specific primers 
(Table 1) for the genes by the spectrofluorometric thermal cycler 
(iCycler; Bio-Rad Laboratories, Hercules, CA, USA). The average 
of gene cycle threshold (Ct) was measured for each experiment. 
Relative cDNA expressions ( )2−∆∆Ct  for the specific genes were 
determined by the compared Ct method, which generates ΔΔCt 
as the discrepancy between the housekeeping genes β-actin and 
the specific gene for each sample.
Beas-2B cell culture and PT Treatment
Phloretin was dissolved in DMSO at a concentration of 100 mM 
to produce a stock solution. After dilution, the DMSO compo-
nent was ≤0.1% of the experimental culture medium. We seeded 
immortalized human bronchial epithelial cells (BEAS-2B) into 
24-well plates with DMEM/F12 medium. Cell cultures were 
pretreated with PT (3–30 µM) for 1 h, then treated with 10 ng/ml 
TNF-α for 24 h, or 10 ng/ml TNF-α and 20 ng/ml IL-4 for 24 h. 
The supernatants were collected, and the levels of cytokines or 
chemokines were determined with specific ELISA kits.
cell–cell adhesion assay
BEAS-2B cells were treated with PT and stimulated with TNF-α 
for 24 h. The human monocytic cell line, THP-1, was cultured and 
stained with calcein-AM solution (Sigma) for 0.5 h, then cocul-
tured with BEAS-2B cells for 1 h. Adherent cells were observed 
and evaluated with fluorescence microscopy (Olympus, Tokyo, 
Japan).
Determination of rOs Production
TNF-α-stimulated BEAS-2B cells treated with PT were seeded 
in 96-well plates for 24 h. Next, cells were stained with 20 µM 
2′,7′-dichlorofluorescin diacetate (DCFH-DA) for 30 min. Then, 
cells were lysed and analyzed with a Multi-Mode Microplate 
Reader (BioTek synergy HT); fluorescence was evaluated by excit-
ing at 485 nm and measuring emission at 528 nm. Furthermore, 
intracellular ROS was visualized with a fluorescence microscope 
(Olympus).
Western immunoblot analysis
Lung tissue proteins were quantified and separated on 10% SDS 
polyacrylamide gels. The proteins were transferred to polyvi-
nylidene fluoride (PVDF) membranes (Millipore, Billerica, MA, 
USA) and incubated with primary antibodies overnight at 4°C. 
Then, membranes were washed and incubated with secondary 
FigUre 1 | The effect of phloretin (PT) on airway hyperresponsiveness (ahr) and cell counts in bronchoalveolar lavage fluid (BalF) of asthmatic 
mice. (a) Changes in AHR (Penh values) with inhalation of increasing methacholine doses (10–40 mg/ml) in normal (N) and OVA-stimulated (OVA) mice, without or 
with PT (PT5-20) treatment (n = 12 mice/group, measured in three independent experiments). (B) Numbers of inflammatory cells and total cells in BALF with 
increasing PT doses; (c) percentage of eosinophils in BALFs from OVA-sensitive mice, treated or untreated with PT. All data are presented as means ± SEM. 
*p < 0.05 compared to OVA control group. **p < 0.01 compared to the OVA control group. Three independent experiments were analyzed and compared with the 
OVA-sensitive mice.
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antibodies. Finally, PVDF membranes were treated with Luminol/
Enhancer Solution (Millipore) to detect antibody signals with 
the BioSpectrum 600 system (UVP, Upland, CA, USA). Primary 
antibodies included anti-HO-1, anti-Nrf2, and anti-Lamin B1 
(Santa Cruz, CA, USA); β-actin expression was evaluated as a 
loading control (Sigma).
statistical analysis
Data were assessed with one-way analysis of variance, followed 
by the Tukey–Kramer post  hoc test for multiple comparisons. 
All values represent the mean ± SEM. Values of p < 0.05 were 
considered significant.
resUlTs
effect of PT on allergen-induced ahr in 
Mice
We evaluated whether PT could improve shortness of breath and 
abnormal airflow in the airways of asthmatic mice. Airway func-
tion was evaluated as the AHR, and the Penh value was calculated 
to determine the AHR. Mice were placed into the single-chamber 
whole-body plethysmograph to record the Penh, during inhala-
tion of various methacholine doses (0–40  mg/ml). We found 
that, upon inhaling methacholine, the Penh value increased 
in a dose-dependent manner. The Penh values were greater in 
OVA-sensitized mice compared to normal mice (Figure  1A). 
At 40  mg/ml of inhaled methacholine, PT-treated asthmatic 
mice showed significantly lower Penh values (PT5, 5.9 ± 0.66, 
p = 0.32; PT10, 4.41 ± 0.58, p < 0.05; PT20, 3.94 ± 0.48, p < 0.01) 
compared to asthmatic mice in the OVA-sensitized group (OVA, 
6.96 ±  0.78). Hence, PT could significantly diminish AHR in 
asthmatic mice.
PT effect on inflammatory cells in BalF
We counted various types of inflammatory cells to assess 
whether PT decreased the inflammatory response in asthmatic 
mice by reducing the numbers of inflammatory cells in BALF 
(Figure  1B). Asthmatic mice treated with PT had significantly 
reduced numbers of eosinophils and total cells compared to the 
OVA group (eosinophils: PT5: 6.2 × 105 ± 6.9 × 104, p = 0.57; 
FigUre 2 | effects of phloretin (PT) on the levels of cytokines and chemokines in bronchoalveolar lavage fluid (BalF). The concentrations of (a) CCL11, 
(B) CCL24, (c) tumor necrosis factor-α (TNF-α), (D) IL-6, (e) IL-4, (F) IL-5, and (g) IL-13 were measured by enzyme-linked immunosorbent assay in BALF from 
normal (N) and OVA-stimulated (OVA) mice, without or with PT (PT5-20) treatment. All data are presented as the means ± SEM. *p < 0.05 compared to the OVA 
control group. **p < 0.01 compared to the OVA control group. Three independent experiments were analyzed and compared with the OVA-sensitive mice.
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PT10: 4.3 × 105 ± 9.3 × 103, p < 0.05; PT20: 3.3 × 105 ± 1.1 × 104, 
p  <  0.01 vs. OVA: 6.4  ×  105  ±  8.9  ×  104) (total cells: PT5: 
1.0 × 106 ± 1.3 × 105, p = 0.84; PT10: 8.4 × 105 ± 1.3 × 104, p = 0.24; 
PT20: 6.3 × 105 ± 1.2 × 104, p < 0.01 vs. OVA: 1.1 × 106 ± 1.0 × 105). 
Furthermore, the proportion of eosinophils in BALF derived from 
the P10 or the P20 group was significantly reduced compared to 
the proportion in the OVA group (Figure 1C).
PT Modulated chemokine and cytokine 
levels in BalF and lung Tissue
The levels of cytokines and chemokines in BALF were determined 
by ELISA (Figure 2). Our results showed that PT could signifi-
cantly suppress IL-4 levels compared to OVA-sensitization alone 
(PT5: 32.4 ± 6.2 pg/ml, p = 0.33; PT10: 24.3 ± 5.2 pg/ml, p < 0.05; 
PT20: 18.5 ± 4.8 pg/ml, p < 0.05 vs. OVA: 41.3 ± 3.8 pg/ml). In 
addition, the PT groups had significantly decreased the levels of 
CCL11, CCL24, TNF-α, IL-6, IL-5, and IL-13 compared to the 
OVA group. A real-time PCR analysis of the expression of genes 
in lung tissue showed that PT could significantly decrease the lev-
els of CCL11, CCL24, and ICAM-1 expression compared to the 
levels in OVA-sensitized asthmatic mice. PT also inhibited IL-4, 
IL-5, IL-13, MUC5AC, Gob5, iNOS, and COX-2 gene expression. 
Furthermore, PT increased the expression of IFN-γ compared to 
the expression in asthmatic mice (Figure 3).
effect of PT on eosinophil infiltration and 
goblet cell hyperplasia in lungs
Eosinophil infiltration in the lungs was evaluated with HE stain-
ing. Compared to normal mice, OVA-sensitized mice exhibited 
more infiltrating eosinophils between the bronchus and blood 
vessels (Figures  4A,B). PT reduced eosinophil infiltration in 
the lungs of asthmatic mice. We evaluated tracheal goblet cell 
hyperplasia with PAS staining. We found that PT could inhibit 
goblet cell hyperplasia compared to untreated, OVA-sensitized 
asthmatic mice (Figures 4C,D).
effects of PT on gsh and MDa activity in 
the lung
Acute asthma attacks can also cause oxidative stress. Previous 
studies showed that the expression of antioxidant HO-1 could 
protect and decrease lung damage during oxidative stress (17). 
We found that the lungs in PT-treated mice had increased 
HO-1 expression of lung compared to asthmatic mice. Nrf2, 
is a transcription factor, could translocate into the nucleus to 
FigUre 3 | Phloretin (PT) effects on cytokine, chemokine, and inflammatory mediator mrna expression in the lungs. Gene expression levels of  
(a) CCL11, (B) CCL24, (c) ICAM-1, (D) IL-4, (e) IL-5, (F) IL-13, (g) IFN-γ, (h) MUC5AC, (i) Gob5, (J) COX-2, and (K) iNOS were determined by real-time RT-PCR 
of RNA extracted from lung tissues of normal (N) and OVA-stimulated (OVA) mice, without or with PT (PT5-20) treatment. Fold changes in expression were 
measured relative to the β-actin expression (internal control). Data are presented as the mean ± SEM. *p < 0.05 compared to OVA control mice. **p < 0.01 
compared to OVA control mice. Three independent experiments were analyzed and compared with the OVA-sensitive mice.
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promote HO-1 expression for antioxidant response. PT could 
increase nuclear Nrf2 expression of lung cells compared to OVA-
sensitized asthmatic mice (Figure 5A). We also found that the 
OVA-sensitized asthmatic mice had significantly increased MDA 
activity and decreased GSH levels in lung tissues compared to the 
levels in normal mice (Figures 5B,C). However, PT significantly 
reduced MDA activity and promoted GSH production in lung 
tissues, compared to the levels in OVA-sensitized asthmatic mice.
PT Modulated splenocyte cytokine levels 
and serum OVa-specific antibody
Splenocyte culture supernatant analyses showed that PT signifi-
cantly attenuated the levels of IL-4, IL-5, and IL-13, compared to 
untreated OVA-sensitized cells. PT also significantly decreased 
the levels of OVA-IgE and OVA-IgG1 in the serum of OVA-
sensitized asthmatic mice (Figure 6).
PT suppressed inflammatory Mediators in 
activated Beas-2B cells
Phloretin could decrease IL-6, IL-8, CCL5, and MCP-1 levels 
in TNF-α-activated BEAS-2B cells. When BEAS-2B cells were 
stimulated with TNF-α and IL-4, PT also significantly inhibited 
CCL11, CCL24, and CCL26 production (Figure 7).
PT reduced Monocytic cell adhesion to 
Beas-2B cells
Phloretin significantly decreased ICAM-1 expression in TNF-α-
activated BEAS-2B cells (Figure 8A). We also evaluated whether 
FigUre 4 | Phloretin (PT) effects on asthmatic lung tissue. Histological sections of lung tissues from normal (N) and OVA-stimulated (OVA) mice, without or 
with PT (PT5-20) treatment. (a) PT reduced eosinophil infiltration; eosinophils are indicated with arrows (hematoxylin and eosin stain; 200× magnification). 
Amplification sections (400× magnification) were shown for the indicated areas. (B) Scoring of inflammation via pathological evaluation of inflammatory cell infiltration 
in lung sections. (c) Periodic acid-Schiff (PAS)-stained lung sections show goblet cell hyperplasia; goblet cells are indicated with arrows (200× magnification).  
(D) Results were expressed as the number of PAS-positive cells per 100 µm of basement membrane. All data are presented as the means ± SEM. *p < 0.05 
compared to the OVA control group. **p < 0.01 compared to the OVA control group. Three independent experiments were analyzed and compared with the 
OVA-sensitive mice.
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PT could inhibit the attachment of THP-1 monocyte cells to 
inflammatory BEAS-2B cells. TNF-α-stimulated BEAS-2B cells 
were cocultured with THP-1 cells (stained with calcein AM). PT 
treatment significantly reduced THP-1 cell adherence to TNF-α-
activated BEAS-2B cells (Figures 8B,C).
effect of PT on rOs Production
BEAS-2B cells were stained with DCFH-DA, the cells were 
lysed, and ROS production was quantified with a Multi-Mode 
Microplate Reader. We found that PT reduced ROS production 
in TNF-α-activated BEAS-2B cells (Figure  9A). Furthermore, 
we examined intracellular ROS in intact cells with a fluorescence 
microscope. We observed that PT attenuated intracellular ROS 
expression in TNF-α-activated BEAS-2B cells (Figures 9B,C).
DiscUssiOn
Phloretin is a bioactive flavonoid derived from the apple tree. It 
has anti-inflammatory effects in inflammatory macrophages and 
human lung epithelial cells (4). Previous studies have shown that 
PT could regulate glucose transporters and increase lipolysis in 
3T3-L1 adipocytes (10, 18). Our previous study found that PT 
improved the inflammatory and oxidative stress in LPS-induced 
acute lung injury mice (12). In the present study, we evaluated 
the hypothesis that PT might ameliorate the pathological mani-
festations of asthma in an asthmatic mouse model. These results 
suggested that PT could ameliorate local asthma symptoms in 
the lung by attenuating Th2 cell activity in the immune system 
of this experimental asthmatic model. PT acted by blocking the 
inflammatory response and alleviating oxidative stress.
Oxidative stress plays an important role in the development 
of several chronic diseases, including cardiovascular disorders, 
cancer, diabetes, and asthma (19). Asthma is a disorder involving 
pulmonary inflammation and allergic reaction; thus, excessive 
oxidative stress would exacerbate airway inflammation and cause 
aggravated bronchospasms that could worsen lung tissue dam-
age (20). In several animal studies, excess ROS was reported to 
increase inflammatory cell infiltration into the lungs, stimulate 
extracellular matrix protein production, and stimulate proinflam-
matory cytokine production in airway epithelial cells (21, 22). It 
was previously shown that natural antioxidants could improve 
the pathological manifestations of asthma by blocking oxidative 
FigUre 5 | Phloretin (PT) effects on oxidative stress factors. (a) Western blot shows PT modulation of HO-1 and Nrf2 expression in lung tissue of normal (N) 
and OVA-stimulated (OVA) mice, without or with PT (PT5-20) treatment. (B) Malondialdehyde (MDA) activity and (c) GSH activity in lung tissues of mice. Data are 
presented as the mean ± SEM. *p < 0.05 compared to OVA control mice. **p < 0.01 compared to OVA control mice. Three independent experiments were 
analyzed and compared with the OVA-sensitive mice.
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FigUre 6 | Phloretin (PT) effects on OVa-specific antibodies in serum. Serum levels of (a) OVA-IgE and (B) OVA-IgG1 are shown from normal (N) and 
OVA-stimulated (OVA) mice, without or with PT (PT5-20) treatment. PT also changed the cytokine levels produced by OVA-activated splenocytes, including (c) IL-4, 
(D) IL-5, and (e) IL-13. All data are presented as the means ± SEM. *p < 0.05 compared to the OVA control group. **p < 0.01 compared to the OVA control group. 
Three independent experiments were analyzed and compared with the OVA-sensitive mice.
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FigUre 7 | continued
10
Huang et al. Phloretin Reduces Asthma in Mice
Frontiers in Immunology | www.frontiersin.org February 2017 | Volume 8 | Article 134
FigUre 8 | Phloretin (PT) inhibited ThP-1 cell adherence to the activated Beas-2B cells. (a) PT decreased the levels of intercellular adhesion molecule 1 
(ICAM-1) in BEAS-2B cells activated with tumor necrosis factor-α (TNF-α). The data represent the mean ± SEM; *p < 0.05, **p < 0.01, compared to BEAS-2B cells 
stimulated with TNF-α. (B) Fluorescence microscopy images of THP-1 cells labeled with calcein AM and mixed with normal (N) and TNF-α-activated BEAS-2B cells, 
in the absence or presence of PT. (c) Fluorescence intensity of monocytic cell adhesion to BEAS-2B cells. The data represent the mean ± SEM; *p < 0.05, 
**p < 0.01, compared to BEAS-2B cells stimulated with TNF-α alone or TNF-α and IL-4. Three independent experiments were analyzed and compared with TNF-α 
alone or TNF-α and IL-4.
FigUre 7 | continued 
Phloretin (PT) effects on cytokine and chemokine production in Beas-2B cells. Enzyme-linked immunosorbent assay results show (a) CCL11, (B) CCL24, 
(c) CCL26, (D) IL-6, (e) IL-8, (F) CCL5, and (g) MCP-1 levels in BEAS-2B cells treated with tumor necrosis factor-α (TNF-α), IL-4, and/or PT. The data represent 
the mean ± SEM; *p < 0.05, **p < 0.01, compared to BEAS-2B cells stimulated with TNF-α alone or TNF-α and IL-4. Three independent experiments were 
analyzed and compared with TNF-α alone or TNF-α and IL-4.
stress in asthmatic mice (4, 23). Other studies showed that PT had 
antioxidative effects on inflammatory colorectal epithelial cells 
and attenuated oxidative reactions in rats that underwent cecal 
ligation and puncture-induced sepsis (24, 25). PT also improved 
oxidative injury in a rat model of cerebral ischemia (24).
Malondialdehyde is a lipid peroxidation marker. It is derived 
from prostaglandin biosynthesis in cells during oxidative stress 
(20). Antioxidant enzymes, such as GSH, catalase, and superox-
ide dismutase, offer protection from oxidation by suppressing the 
chronic inflammatory response and preventing the deterioration 
of lung tissue in allergic asthma (20, 22). In the current study, 
we demonstrated that PT significantly decreased MDA and 
increased GSH, which ameliorated oxidative stress in lung tissues 
of asthmatic mice. We also found that PT could increase nuclear 
Nrf2 expression, which contributed to increasing HO-1 expres-
sion, and provided protection from oxidation in asthmatic lungs. 
Furthermore, our findings demonstrated that PT could suppress 
ROS production in TNF-α-activated human tracheal epithelial 
cells. Hence, we showed that PT could provide antioxidative 
effects to ameliorate lung injury in asthma.
Airway hyperresponsiveness is an important feature of asthma. 
Allergens might induce an acute asthma attack, which presents as 
bronchoconstriction and severe shortness of breath (1). Clinically, 
asthma is diagnosed in both children and adults by measuring the 
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FigUre 9 | Phloretin (PT) effects on reactive oxygen species (rOs) production in activated Beas-2B cells. (a) Percentages of ROS detected in tumor 
necrosis factor-α (TNF-α)-activated BEAS-2B cells in the absence or presence of PT, compared to untreated cells (N); (B) fluorescence microscopy images of 
intracellular ROS. (c) Fluorescence intensity of intracellular ROS. Data represent the mean ± SEM; **p < 0.01, compared to BEAS-2B cells stimulated with TNF-α 
alone. Three independent experiments were analyzed and compared with TNF-α alone or TNF-α and IL-4.
AHR, evaluating the airflow, and investigating the pathological 
features of asthma (22, 26). In patients with asthma, oxidative 
stress enhances the production of proinflammatory mediators, 
increases the AHR, and stimulates mucin secretion in the air-
ways (27). PT significantly reduced elevations in inflammatory 
mediators in BALF and lung tissue of OVA-induced asthmatic 
mice and decreased proinflammatory cytokines and chemokines 
in human tracheal epithelial cells; thus, PT could ameliorate lung 
damage in asthma. Previous studies suggested that IL-13, which is 
a Th2-associated cytokine, could aggravate AHR in patients with 
asthma (28). In patients with asthma, where airway function is 
deteriorated and inflammatory responses are induced, high IL-13 
levels have been observed in BALF and lung (29). We found that 
PT treatment reduced the IL-13 levels in BALF and suppressed 
IL-13 gene expression in the lungs of asthmatic mice, which may 
have contributed to AHR attenuation.
Excessive secretion of Th2 cytokines exacerbates the severity 
of an allergic response by increasing inflammatory cell infiltra-
tion and inducing goblet cell hyperplasia, which in turn, causes 
excess mucus secretion in asthmatic lungs (4, 30). In patients 
with asthma, Th2 cells release elevated IL-5 levels, which increase 
eosinophil differentiation in bone marrow cells (6). Eotaxins 
(CCL11 CCL24, and CCL26) are thought to attract eosinophil 
migration into inflamed lung tissues, and the release of more 
inflammatory mediators by activated eosinophils increases lung 
tissue injury (5, 29). Previous study demonstrated that eosinophil 
would secret major basic protein for induced mast cell degranula-
tion to exacerbate allergy response (6). Eosinophil also released 
eosinophil cationic protein and eosinophil peroxidase to create 
the transmembrane channels for cytotoxic molecules into the 
cell (29). Hence, eosinophils accumulation in lung tissue would 
cause serious asthmatic allergy and inflammatory response. 
Eosinophils also induced the development of airway remodeling 
(5). Our results demonstrated that PT could inhibit IL-5, CCL11, 
and CCL24 expression in the lungs and BALF of asthmatic mice. 
PT also decreased the levels of CCL11, CCL24, and CCL26 in 
inflamed tracheal epithelial cells. Additionally, PT also reduced 
ICAM-1 in inflamed tracheal epithelial cells, which reduced 
their ability to adhere to inflammatory cells in lung tissues. 
Thus, PT could reduce eosinophil infiltration into lung tissue by 
blocking IL-5 and eotaxin production. Furthermore, activated 
macrophage also released more inflammatory cytokines to 
destroy the function of lung cell (31). In our murine asthma 
model, we found that asthma mice did not significantly increase 
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